Cardiac Rehabilitation in Chagas Heart Failure
Launched by EVANDRO CHAGAS NATIONAL INSTITUTE OF INFECTIOUS DISEASE · Aug 3, 2015
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
The present study consisted in a pre/post single-arm intervention study conducted at the Evandro Chagas National Institute of Infectious Disease (INI), located on Rio de Janeiro, Brazil. INI is a national reference center for treatment and research in infectious diseases and tropical medicine in Brazil, which follows a large cohort of patients with Chagas disease, all of them diagnosed by two simultaneously positive serological tests (enzyme-linked immunosorbent assay and indirect immunofluorescence). Patients included in the study were submitted to a physical exercise intervention protocol...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients at the stages C or D of Chagas cardiomyopathy
- • Patients receiving standard optimized medical therapy
- • Patients with good adherence to outpatient treatment within the last three months.
- Exclusion Criteria:
- • Those who were not able to attend three weekly training sessions,
- • Those who had neuromuscular limitations, cardiopathies from non-Chagasic etiology (e.g ischemic), systemic conditions that limits exercise practice (e.g chronic obstructive pulmonary disease)
- • Practitioners of regular exercise.
About Evandro Chagas National Institute Of Infectious Disease
The Evandro Chagas National Institute of Infectious Disease (INI) is a prestigious research institution based in Brazil, dedicated to the study and management of infectious diseases. As a key component of the Oswaldo Cruz Foundation (Fiocruz), the INI focuses on advancing knowledge in epidemiology, clinical research, and public health, with an emphasis on diseases endemic to the region. The institute plays a vital role in conducting clinical trials aimed at developing innovative diagnostics, treatments, and preventive measures, thereby contributing to global health initiatives and improving health outcomes for affected populations. Through its multidisciplinary approach and collaboration with national and international partners, the INI fosters a robust research environment that addresses pressing health challenges in infectious disease management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rio De Janeiro, Rj, Brazil
Patients applied
Trial Officials
Andrea S Sousa, PhD
Principal Investigator
Evandro Chagas National Institute of Infectious Disease
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials